地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:17754422825
传真:15172469628
邮箱:sales@amyjet.com
<艾美捷科技代理Purepeg品牌全系列产品
PurePEG, LLC是一家致力于为学术和商业用户提供高质量、高纯度单分散聚乙二醇(PEG)及其相关产品的领先供应商,提供具有不同重复单元(间隔基长度)、末端官能团(X 和 Y)以及多种分子结构(线性、支化和多臂型)的产品。PurePEG 凭借多年研发积累的创新 PurePEG 技术,能够生产具有精确分子量的纯净、单分散 PEG。PurePEG 开发了首个用于偶联抗体与毒素(ADC药物)以治疗乳腺癌的酸功能化PEG。PEG因其水溶性、无毒性和非免疫原性等特性,已在生物医学领域确立了重要地位。迄今为止,已有 12 种经 FDA 批准的聚乙二醇化药物用于治疗多种慢性疾病。此外,PurePEG提供从毫克级到公吨级多种PEG产品的高质量定制合成与合同研发服务。

▍Purepeg产品线
PurePEG提供以下相关目录产品:
| Diselenide Linkers | Clickable Linkers | PEG45 | Linker with protecting group |
| Peptide Linkers | BCN Linker | PEG-Lipid | Biotinylation Reagents |
| Polydisperse PEG | BCN linker (non PEG) | PEGylation Reagents | Multi-Arm PEGs |
| PROTAC | Diazirine Linker | Heterobifunctional PEGs | Cleavable Linkers |
| Chelating Agent | Porphyrin | Homobifunctional PEGs | Non-PEG Linkers |
▍Purepeg部分产品列表
| 品名 | 货号 | CAS号 | 分子式 | 分子量 |
| 3,3′-Diselenobispropionic acid | 512371 | 7370-58-3 | C6H10O4Se2 | 304.06 |
| di-tert-butyl 3,3′-diselanediyldipropionate | 512282 | N/A | C14H26O4Se2 | 416.3 |
| 2,2′-diselanediyldiacetic acid | 512361 | 16066-50-5 | C4H6O4Se2 | 276.01 |
| di-tert-butyl 2,2′-diselanediyldiacetate | 512281 | N/A | C12H22O4Se2 | 389.98 |
| Azido-PEG4-Val-Ala-PAB-PNP | 5126604 | N/A | C33H45N7O12 | 731.8 |
| Azido-PEG4-Val-Ala-PAB | 5116604 | N/A | C26H42N6O8 | 566.7 |
| Mal-amide-PEG6-Val-Cit-PAB-OH | 516206 | 3034751-42-0 | C40H63N7O14 | 865.4 |
| Mal-PEG8-amide-Val-Ala-Exatecan | 5116208 | N/A | C58H78FN7O18 | 1179.539 |
| MC-Val-Cit-PAB-PNP | 51057 | 159857-81-5 | C35H43N7O11 | 737.8 |
| MC-Val-Ala-PAB-OH | 51056 | 1870916-87-2 | C25H34N4O6 | 486.56 |
| MC (C5)-Val-Cit | 51055 | 2504147-59-3 | C20H31N5O7 | 453.5 |
| SPDP-Val-Cit-PAB-PNP | 51054 | N/A | C33H39N7O9S2 | 741.8 |
| SPDP-Val-Cit-PAB-OH | 51053 | N/A | C26H36N6O5S2 | 576.7 |
| Alloc-Val-Ala-PAB | 51051 | 1343407-91-9 | C19H27N3O5 | 377.4 |
| DBCO-PEG4-Val-Ala-PAB | 5114804 | 2348405-92-3 | C45H57N5O10 | 827.9 |
| Boc-PEG2-Val-Cit-PAB-OH | 512702 | 2055024-55-8 | C30H50N6O9 | 638.75 |
| endo BCN-PEG3-VC-PFP Ester | 5196303 | 2353409-45-5 | C37H50F5N5O10 | 819.8 |
| endo BCN-PEG3-Val-Cit | 511203 | N/A | C31H51N5O10 | 653.8 |
| Azido-PEG3-Val-Cit-PAB-PNP | 516603 | 2055047-18-0 | C34H47N9O12 | 773.8 |
| Azido-PEG4-Val-Cit-PAB-OH | 516604 | 2055024-64-9 | C29H48N8O9 | 652.8 |
| Boc-PEG4-Val-Cit-PAB-OH | 512704 | 2055024-54-7 | C34H58N6O11 | 726.86 |
| Boc-PEG6-Val-Cit-PAB-OH | 512706 | 2055024-53-6 | C38H66N6O13 | 814.96 |
| 6-Azidohexanoyl-Val-Cit-PAB | 51047 | 1613321-01-9 | C24H38N8O5 | 518.61 |
| DBCO-PEG4-Val-Cit-PAB-PNP | 514804 | 2226472-28-0 | C55H66N8O15 | 1079.2 |
invivoCrown IV0111替换BioXCell BE0036
invivoCrown IV0113替换BioXCell BE0075
invivoCrown IV0102替换BioXCell BE0003-1

艾美捷科技代理Emfret品牌。
Emfret是一家专注于免疫学和血液学研究的生物技术公司,以其高质量的抗体和试剂而闻名,特别是在血小板和免疫细胞研究领域。
| Emfret公司的产品与服务 |
● 抗体
血小板抗体:用于检测和研究血小板表面标记和功能。
免疫细胞抗体:用于T细胞、B细胞、单核细胞等免疫细胞的研究。
● 试剂盒
血小板功能检测试剂盒:用于评估血小板活化和聚集。
免疫细胞分型试剂盒:用于多参数流式细胞术分析。
● 定制服务:
抗体开发:根据客户需求开发定制抗体。
试剂盒定制:根据客户需求设计定制试剂盒。
| Emfret产品应用领域 |
● 血液学研究,用于血小板功能和血液疾病研究。
● 免疫学研究,用于免疫细胞表型和功能研究。
● 癌症研究,用于肿瘤免疫微环境和循环肿瘤细胞研究。
● 传染病研究,用于病原体特异性免疫反应研究。
● 临床诊断,支持血液和免疫相关疾病的诊断和监测。
<| 产品列表 |
| Cat.No. | Antigen | Clone | Isotype | Form | Applications | Size |
| C301 | Antibodies for Mouse Platelet Depletion | polyclonal non-immune rat immunoglobulins | Rat IgG | purif. | negative control for #R300 | 0.5 mg |
| D200 | Two-Color Analysis of Mouse Platelet Activation | Wug.E9 JON/A | Rat IgG2b/IgG1 | FITC PE | flow cytometry | 2 x 1.0 ml; 200 tests |
| M011-0 | GPVI | JAQ1 | Rat IgG2a | purif. | IP, IHC, WB | 0.1 mg |
| M011-1 | GPVI | JAQ1 | Rat IgG2a | FITC | FC, IHC | 1.5 ml; 300 tests |
| M021-0 | Integrin alphaIIbbeta3 (GPIIb/IIIa, CD41/CD61) | Leo.H4 | Rat IgG2b | purif. | IP, IHC, block | 0.5 mg |
| M021-1 | Integrin alphaIIbbeta3 (GPIIb/IIIa, CD41/CD61) | Leo.H4 | Rat IgG2b | FITC | FC, IHC | 1.5 ml; 300 tests |
| M022-0 | Integrin alphaIIbbeta3 (GPIIb/IIIa, CD41/CD61) | Leo.A1 | Rat IgG1 | purif. | IP, IHC | 0.5 mg |
| M023-2 | Integrin alphaIIbbeta3 (GPIIb/IIIa, CD41/CD61) | JON/A | Rat IgG2b | PE | FC (activ. form) | 1.5 ml; 300 tests |
| M024-0 | Integrin alphaIIb (GPIIb, CD41) | MwReg30 | Rat IgG1 | purif. | IP, IHC, generation of Fab fragments | 6 mg |
| M025-0 | Integrin alphaIIbbeta3 (GPIIb/IIIa, CD41/CD61) | Leo.F2 | Rat IgG2a | purif. | IP, IHC | 0.5 mg |
| M025-1 | Integrin alphaIIbbeta3 (GPIIb/IIIa, CD41/CD61) | Leo.F2 | Rat IgG2a | FITC | FC, IHC | 1.5 ml; 300 tests |
| M025-2 | Integrin alphaIIbbeta3 (GPIIb/IIIa, CD41/CD61) | Leo.F2 | Rat IgG2a | PE | FC, IHC | 1.5 ml; 300 tests |
| M025-3 | Integrin alphaIIbbeta3 (GPIIb/IIIa, CD41/CD61) | Leo.F2 | Rat IgG2a | DyLight 649 | FC, IHC | 1.5 ml; 300 tests |
| M030-0 | Integrin beta3 chain (GPIIIa, CD61) | Luc.A5 | Rat IgG2a | purif. | IP, IHC, WB | 0.5 mg |
| M031-0 | Integrin beta3 chain (GPIIIa, CD61) | Luc.H11 | Rat IgG2b | purif. | IP, IHC, WB | 0.5 mg |
| M031-1 | Integrin beta3 chain (GPIIIa, CD61) | Luc.H11 | Rat IgG2b | FITC | FC, IHC | 1.5 ml; 300 tests |
| M040-0 | GPIbalpha (CD42b) | Xia.G5 | Rat IgG2b | purif. | IP, IHC | 0.5 mg |
| M040-1 | GPIbalpha (CD42b) | Xia.G5 | Rat IgG2b | FITC | FC, IHC | 1.5 ml; 300 tests |
| M040-2 | GPIbalpha (CD42b) | Xia.G5 | Rat IgG2b | PE | FC, IHC | 1.5 ml; 300 tests |
| M040-3 | GPIbalpha (CD42b) | Xia.G5 | Rat IgG2b | DyLight 649 | FC, IHC | 1.5 ml; 300 tests |
| M041-0 | GPIbalpha (CD42b) | Xia.H10 | Rat IgG2a | purif. | FC, IHC | 0.5 mg |
| M041-1 | GPIbalpha (CD42b) | Xia.H10 | Rat IgG2a | FITC | FC, IHC | 1.5 ml; 300 tests |
| M042-0 | GPIbalpha (CD42b) | Xia.G7 | Rat IgG1 | purif. | IP, IHC, WB | 0.5 mg |
| M042-1 | GPIbalpha (CD42b) | Xia.G7 | Rat IgG1 | FITC | FC, IHC | 1.5 ml; 300 tests |
| M043-0 | GPIbalpha (CD42b) | Xia.B2 | Rat IgG2a | purif. | IP, IHC, block | 0.5 mg |
| M043-1 | GPIbalpha (CD42b) | Xia.B2 | Rat IgG2a | FITC | FC, IHC | 1.5 ml; 300 tests |
| M050-0 | GPIbbeta (CD42c) | Xia.C3 | Rat IgG2a | purif. | IP, IHC, WB | 0.5 mg |
| M050-1 | GPIbbeta (CD42c) | Xia.C3 | Rat IgG2a | FITC | FC, IHC | 1.5 ml; 300 tests |
| M051-0 | GPIX (CD42a) | Xia.B4 | Rat IgG1 | purif. | IP, IHC | 0.5 mg |
| M051-1 | GPIX (CD42a) | Xia.B4 | Rat IgG1 | FITC | FC, IHC | 1.5 ml; 300 tests |
| M060-1 | GPV (CD42d) | Gon.C2 | Rat IgG1 | FITC | FC, IHC | 1.5 ml; 300 tests |
| M061-0 | GPV (CD42d) | Gon.G6 | Rat IgG2a | purif. | IP, IHC | 0.5 mg |
| M061-1 | GPV (CD42d) | Gon.G6 | Rat IgG2a | FITC | FC, IHC | 1.5 ml; 300 tests |
| M070-0 | Integrin alpha2 chain (CD49b, GPIa) | Sam.G4 | Rat IgG2b | purif. | IP, IHC, block | 0.5 mg |
| M070-1 | Integrin alpha2 chain (CD49b, GPIa) | Sam.G4 | Rat IgG2b | FITC | FC, IHC | 1.5 ml; 300 tests |
| M071-0 | Integrin alpha2 chain (CD49b, GPIa) | Sam.C1 | Rat IgG2b | purif. | IP, IHC | 0.5 mg |
| M071-1 | Integrin alpha2 chain (CD49b, GPIa) | Sam.C1 | Rat IgG2b | FITC | FC, IHC | 1.5 ml; 300 tests |
| M080-0 | Integrin alpha5 chain (CD49e) | Tap.A12 | Rat IgG1 | purif. | IP, IHC | 0.5 mg |
| M080-1 | Integrin alpha5 chain (CD49e) | Tap.A12 | Rat IgG1 | FITC | FC, IHC | 1.5 ml; 300 tests |
| M110-0 | CD9 | Nyn.H3 | Rat IgG2a | purif. | IP, IHC, WB | 0.5 mg |
| M110-1 | CD9 | Nyn.H3 | Rat IgG2a | FITC | FC, IHC | 1.5 ml; 300 tests |
| M120-0 | CD31 (PECAM-1) | Pec.H3 | Rat IgG1 | purif. | IP, IHC, WB | 0.5 mg |
| M130-0 | CD62P (P-selectin) | Wug.E9 | Rat IgG1 | purif. | IP, IHC | 0.5 mg |
| M130-1 | CD62P (P-selectin) | Wug.E9 | Rat IgG1 | FITC | FC, IHC | 1.5 ml; 300 tests |
| M130-2 | CD62P (P-selectin) | Wug.E9 | Rat IgG1 | PE | FC, IHC | 1.5 ml; 300 tests |
| P140-1 | fibrinogen | polyclonal | Rabbit IgG | FITC | FC, IHC | 1.5 ml; 300 tests |
| P150-1 | von Willebrand Factor (vWF) | polyclonal | Rabbit IgG | FITC | FC, IHC | 1.5 ml; 300 tests |
| P180-1 | negative control | polyclonal | Rabbit IgG | FITC | FC, IHC | 1.0 ml; 200 tests |
| P190-1 | negative control | polyclonal | Rat IgG | FITC | FC, IHC | 1.0 ml; 200 tests |
| P190-2 | negative control | polyclonal | Rat IgG | PE | FC, IHC | 1.0 ml; 200 tests |
| P190-3 | negative control | polyclonal | Rat IgG | DyLight 649 | FC, IHC | 1.0 ml; 200 tests |
| R300 | Antibodies for Mouse Platelet Depletion | polyclonal anti-GPIb alpha | Rat IgG | purif. | platelet depletion | 0.5 mg |
| X488 | Antibodies for In Vivo Mouse Platelet Labeling | anti - GPIbbeta derivative | Rat IgG | DyLight 488 | in vivo | 100 µg |
| X649 | Antibodies for In Vivo Mouse Platelet Labeling | anti - GPIbbeta derivative | Rat IgG | DyLight 649 | in vivo | 100 µg |
invivoCrown IV0115替换BioXCell BE0060
invivoCrown IV0102替换BioXCell BE0003-1

艾美捷科技代理DCN Dx品牌全系列产品
DCN Dx是一家专注于体外诊断(IVD)领域内快速即时诊断(POC)检测试剂的开发和制造的公司。快速免疫检测试剂的合约开发是DCN Dx所有业务的核心。Dcndx公司专注于侧向层析法(lateral flow)、穿流法(flow through)和微流控(microfluidic)技术平台,具有高灵敏度、定量检测、多重检测以及读数仪集成的高质量要求。DCNDx还提供多种产品和服务,以协助客户在开发的任何阶段:
● 定制的、私有的侧向层析技术教育培训课程: 在此课程中,将教授如何开发和制造快速检测试剂的细节;
● 咨询服务: 协助解决快速检测试剂开发、生产、法规注册和商业化过程中的任何问题;
● 定制化的蛋白-蛋白、蛋白-颗粒、小分子-蛋白和小分子-颗粒结合物;
● 侧向层析材料入门套件、结合物试剂盒、试剂、测试卡盒和材料: 用于快速检测试剂的开发过程。
▍DCN Dx产品列表
| 品名 | Weight | Dimensions | 产品描述 |
| Blood Collection/Separation Materials Kit | 5.5 LBS | 10 × 14 × 3.5 IN | 集血液采集与红细胞分离功能于一体的套装设备 |
| Nucleic Acid Lateral Flow Kit | 2 LBS | 14 × 12 × 4 IN | 兼容 DTT 的试剂盒检测标记的 DNA 扩增产物 |
| Basic Lateral Flow Training | - | - | 侧向层析技术能力提升 |
| MICA-200C LFA Cassettes | 1.5 LBS | 12.25 × 11 × 1.5 IN | 高性能侧向层析 (LFA)卡盒 |
| Lateral Flow Materials Kits | 16 LBS | 16 × 16 × 16 IN | 侧向层析材料套件 |
| Colloidal Gold | 2.5 LBS | 8.5 × 3.5 × 3.5 IN | DCNovations胶体金,提供大宗采购优惠价 |
| Cellulose NanoBeads | - | - | 采用 NanoAct™纤维素纳米珠,增强侧向层析检测性能 |
| CNB Conjugation Kit | 8 LBS | 16 × 16 × 16 IN | 为NanoAct™纤维素纳米珠提供可靠的偶联解决方案 |
| Colloidal Gold Conjugation Kit | 9 LBS | 16 × 16 × 16 IN | 胶体金偶联试剂盒,优化蛋白-金标记物偶联物 |
" data-original="http://aves.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理DCN Dx品牌全系列产品"> 艾美捷科技代理DCN Dx品牌全系列产品
invivoCrown IV0107替换BioXCell BE0273
地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18372041646
传真:17754422825
邮箱:sales@amyjet.com
0.1112